Insulin degludec: a significant advancement in ultralong-acting Basal insulin.
Ontology highlight
ABSTRACT: This editorial discusses a novel basal insulin analog, insulin degludec. It describes the limitations of existing basal insulins, and builds the case for a better analog. The editorial discusses the evidence to support the efficacy, safety, tolerability, and flexibility of degludec, and assesses its utility as part of a person-centered approach to diabetes management.
SUBMITTER: Kalra S
PROVIDER: S-EPMC3889334 | biostudies-literature |
REPOSITORIES: biostudies-literature
ACCESS DATA